Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

Clinical trial NCT01346969 · COMPLETED

Trial details

NCT number: NCT01346969
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Reduction in Hypertrophic Skin Scarring

Start date: 2011-06-01
Primary completion: 2012-04-16
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.